5-N-tert-butyl-7-N-(cyclobutylmethyl)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridine-5,7-diamine
C24H33N5OS — CID 162785056
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-N-tert-butyl-7-N-(cyclobutylmethyl)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridine-5,7-diamine
5-N-tert-butyl-7-N-(cyclobutylmethyl)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridine-5,7-diamine (PubChem CID 162785056) has the molecular formula C24H33N5OS and a molecular weight of 439.63 g/mol. Its IUPAC name is 5-N-tert-butyl-7-N-(cyclobutylmethyl)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridine-5,7-diamine.
Molecular Properties
| Compound Name | 5-N-tert-butyl-7-N-(cyclobutylmethyl)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridine-5,7-diamine |
|---|---|
| PubChem CID | 162785056 |
| Molecular Formula | C24H33N5OS |
| Molecular Weight | 439.63 g/mol |
| Exact Mass | 439.24 |
| IUPAC Name | 5-N-tert-butyl-7-N-(cyclobutylmethyl)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridine-5,7-diamine |
| SMILES | CC(C)(C)Nc1cc(NCC2CCC2)c2sc(-c3ccnn3C3CCCCO3)cc2n1 |
| InChI | InChI=1S/C24H33N5OS/c1-24(2,3)28-21-14-17(25-15-16-7-6-8-16)23-18(27-21)13-20(31-23)19-10-11-26-29(19)22-9-4-5-12-30-22/h10-11,13-14,16,22H,4-9,12,15H2,1-3H3,(H2,25,27,28) |
| InChIKey | YBFYHDAFHNDJQZ-UHFFFAOYSA-N |
| XLogP | 6.28 |
| TPSA | 64.00 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 439.63 |
| LogP ≤ 5 | 6.28 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162785056 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.